Moreover, this abrogates the upregulation by PLZF of REDD1, a known inhibitor of mTORC1 [146], therefore suggesting that KLK4, as a molecular switch integrating AR and mTOR, is a viable target in PCa [145]. This evidence concerns the gene ZBTB16 and posterior cortical atrophy.